Chapter
1.4 Polymeric Biomaterials
1.5 Composite Biomaterials
1.6 Additive Manufacturing (AM) of Biomaterials
1.7 Biomaterials in Orthopedic Implants Devices
1.7.2 Implants used in osteosynthesis for stabilization and fracture repair
1.7.4 Nonconventional implants for bone tumor
1.7.5 Multifunctional devices
1.8 Summary and Future Directions
2 Bone Biology and Effects of Pharmaceutical Intervention on Bone Quality
2.1.4.2 Osteoblast lineage
2.1.4.2.1 The Wnt-signaling system
2.1.4.5 Mature osteoblasts
2.1.5.1 The basic multicellular unit
2.1.5.2 Sequence of bone remodeling
2.1.5.2.7 Reestablishing osteocyte network
2.1.6.2 Complete fractures
2.1.7 Aspects of bone strength
2.1.7.3 Mineralization density
2.1.7.4 Microarchitecture
2.1.7.5 Collagen structure
2.1.7.6 Ability to repair damage
2.1.7.7 Crystal characteristics
2.1.7.9 Overall bone strength
2.2 Pharmaceutical Intervention
2.2.1 Bone loss with aging or disease
2.2.2 Actions of systemic hormones and local cytokines
2.2.2.2 Glucocorticosteroids
2.2.2.6 1,25 (OH)2-Cholecalciferol (1,25D)
2.2.2.7 Insulin and insulin-like growth factor
2.2.3 Calcium supplementation
2.2.4 Bone formation with osteoporosis medications
2.2.6.1 Short-term effects
2.2.6.2 Long-term effects
2.2.10 Emerging therapies
2.2.10.1 Cathepsin K inhibitors
2.2.11 Other medications or substances that affect bone strength
2.2.11.2 Selective serotonin reuptake inhibitors
2.2.11.3 Carbonic anhydrase inhibitors
2.2.11.4 Thiazide diuretics
2.2.11.8 Elements toxic to the bone
3.3 Degenerative Disc Disease
3.7 Summary and Future Directions
4 Implants for Joint Replacement of the Hip and Knee
4.1 Historical Perspective
4.2 Design and Material Issues, Clinical Outcome
4.2.1 Current bearing materials in hip and knee replacement
4.2.1.1 New polyethylenes
4.2.1.2 Ceramic-on-ceramic bearings
4.2.1.3 Metal-on-metal bearings
4.2.2 Cemented hip arthroplasty
4.2.2.1 Acrylic bone cement: Polymethylmethacrylate
4.2.2.2 Firmness and durability of implant–cement composite
4.2.2.3 Material and design of cemented implants
4.2.2.4 Cementing technique during THA
4.2.2.5 Clinical evidence for cemented THA
4.2.2.6 Clinical evidence for partially cemented THA (cementless cup-cemented stem)
4.2.2.7 Current indications for cemented or partially cemented THA
4.2.3 Cementless hip arthroplasty
4.2.4 Cemented total knee replacement
4.3 Current Critical Issues
4.3.1 Introduction of new technologies to orthopedics
4.3.2 Younger more active patient population
4.3.2.2 Surgical technique
4.3.2.3 Design and material options
4.3.3 Prosthetic joint infection
4.3.3.1 Prevention of PJI
4.3.4 Wear and osteolysis
4.3.4.1 Wear of prosthetic surfaces
4.3.4.2 Periprosthetic osteolysis
4.3.4.3 Strategies aimed at diminishing the risk for osteolysis and aseptic loosening
4.3.5 Hip: Other concerns (dislocation, big heads, alternative bearing surfaces, head–neck taper interface)
4.3.5.3 Treatment of dislocated THA
4.3.5.4 Modular component exchange
4.3.5.5 Reorientation of THA
4.3.5.6 Improvement of abductor moment
4.3.5.7 Dual-mobility cups
4.3.5.8 Constrained liners
4.3.5.9 Large femoral heads
4.3.5.10 Concerns related to large femoral heads
4.3.5.11 Alternative bearing surfaces
4.3.5.12 Ceramic-on-ceramic
4.3.5.14 Ceramic-on-metal
4.3.5.16 Carbon-fiber-reinforced polyaryletheretherketone
4.3.5.17 Head–Neck taper interface damage
4.3.6 Other issues with TKA (malalignment, stiffness, allergy, patient satisfaction)
4.3.7 Patients with severe bone-related comorbidities (elderly patients with osteoporosis, patients with rheumatic diseases...
4.3.7.1.1 Indication for THA/TKA
4.3.7.1.2 Design and material options
4.3.7.2 Systemic inflammatory diseases
4.3.7.2.1 Design and material options
4.3.7.2.2 Evidence for THA/TKA
4.3.7.3 Osteonecrosis of the hip
4.3.7.3.1 Indication for THA
4.3.7.3.2 Design and material option
4.3.7.3.3 Evidence for THA
4.3.7.4.1 Design and material option
4.3.7.4.2 Evidence for THA/TKA
4.3.7.5.1 Design and material option
4.3.7.5.2 Evidence for THA/TKA
4.4 Future Trends and Next-Generation Devices
4.4.1 Improved patient selection
4.4.2 Improved surgical technique and instrumentation
4.4.3 Improved implant design
4.4.4 Improved bearing surfaces
4.4.5 Improving implant integration and avoiding infection
5 Material and Mechanobiological Considerations for Bone Regeneration
5.2 Physiology of Bone Regeneration
5.2.1 Inflammation and hematoma
5.2.2 Soft callus and neovascularization
5.3 Mechanical Properties of Materials for Bone Regeneration
5.3.1 Native bone and grafts
5.3.6 FDA regulatory pathways and testing considerations
5.4 Cell-Level Mechanobiology of Bone Regeneration
5.4.1 Cell-level mechanosensors
5.4.2 Intrinsic physical factors
5.4.3 Extrinsic physical factors
5.5 Tissue-Level Mechanobiology of Bone Regeneration
5.5.1 In vivo mechanobiology of bone regeneration
5.5.2 Computational modeling of bone regeneration
5.6 Conclusions and Future Directions
6 Ceramics in Bone Grafts and Coated Implants
6.3.1 Bioceramics and bone remodeling
6.3.2 Role of trace elements on bioactivity of bioceramics
6.4.1 Ceramic scaffold fabrication techniques
6.4.2 In vitro and in vivo properties of bone scaffolds
6.4.3 In vivo and in vitro performance of CaP–polymer composite scaffold
6.5 Ceramics in Drug Delivery
6.6.1 Challenges of HA coatings
6.6.2 Significance of HA coating in revision surgeries
6.6.3 Coating properties and characterization standards
6.6.3.1 Crystallographic Information
6.6.3.2 Environmental stability
6.6.3.3 Tensile bond strength
6.6.4 Coating preparation techniques
6.6.4.1 Plasma-sprayed HA coating
6.6.4.2 Laser-assisted coating
6.6.4.3 Electrophoretic deposition
6.6.4.4 Sol-gel deposition
6.6.4.5 Biomimetic deposition
6.6.4.6 Compositionally graded coating
6.8 Bioglass for Bone Regeneration
6.9 Summary and Future Directions
7 Ceramic Coatings in Load-Bearing Articulating Joint Implants
7.2 Knee Simulator Study Involving NSD-Coated Titanium Articulating Against Polyethylene
7.3 Knee Simulator Study Involving Articulation of NSD on NSD
7.4 Role of Ceramic-Boriding on CoCr for Subsequent CVD Diamond Deposition
7.5 Biocompatibility and Osteo-Integration of Nanodiamond Coated Implant
7.6 Nanodiamond (ND) Wear-Debris and Influence of Size and Concentration of Wear-Debris on Inflammation
7.7 Summary and Future Perspectives
8 Polymers and Composites for Orthopedic Applications
8.2 Nondegradable Polymers and Composites for Orthopedic Applications
8.2.1 Poly(methyl methacrylate)
8.2.2 Polyaryletherketones
8.2.3 Ultrahigh-molecular-weight polyethylene
8.2.6 Polydimethylsiloxane
8.3 Biodegradable Polymers and Composites for Orthopedic Applications
8.3.1.5 Poly(amino acids) and pseudo poly(amino acids)
8.3.2.1 Protein-based polymers
8.3.2.2 Polysaccharide-based polymers
8.3.2.3 Natural polyesters (polyhydroxyalkanoates)
8.4 Major Applications of Polymers and Their Composites for Orthopedic Applications
8.4.1 Bone-related applications
8.4.1.2 Bone replacements
8.4.1.3 Bone repair and regeneration
8.4.1.4 Plates, pins, nails, and screws
8.4.2 Spinal applications
8.4.2.1 Intervertebral disc replacement and regeneration
8.4.2.2 Spacer in intervertebral artificial disc replacement
9 Surface Modifications and Surface Characterization of Biomaterials Used in Bone Healing
9.1.1 Objective of this chapter
9.2 Current Biomaterials for Bone Healing
9.2.5 Bone substitute used in oral and maxillofacial bone disorders
9.3 Use of Precision Manufacturing to Improve Biomaterials Fabrication and Biological Response
9.3.1 Nano-phase methods of biomaterials fabrication
9.3.2 Surface adhesion molecules on cell membranes
9.3.3 Examples of surface modification
9.3.4 Photolithography processing
9.3.5 Deep reactive ion etching
9.3.6 Surface modification by overlays or coatings
9.3.6.1 Plasma-enhanced chemical vapor deposition coating
9.3.7 Surface modification of solid-state micropores for selective cell surface binding
9.3.8 Surface biomolecular functionalization
9.3.9 Surface functionalization example: preparation of anti-EGFR aptamers
9.3.10 Immobilization of aptamers on SiO2 substrate
9.3.11 Protein binding and electrical detection
9.4 Surface Characterization of Biomineral and Biomaterial Surfaces
9.4.1 Microcomputed tomography measurements
9.4.2 Raman spectroscopy analysis
9.4.3 Electron microscopy
9.4.5 Surface compositional analysis
9.4.6 Optical property characterization
9.4.7 Fourier transform infrared (FTIR) spectroscopy analysis
9.4.7.1 Biological surface characterization
9.4.7.1.1 In vitro bioactivity testing of SiONx and SiONPx coatings
9.4.8 SBF dissolution test
9.4.9 Inductively coupled plasma-optical emission spectra (ICP-OES) analyses
9.4.10 Thermodynamics of surfaces: surface energy and surface tension
9.4.10.1 Goniometric analysis
9.4.11 Cell proliferation analysis
9.4.12 Cell differentiation analysis
9.4.13 X-ray absorption near-edge structure analyses
9.4.14 Histological staining for collagen elongation
9.5 Current Challenges and Future Trends
9.5.1 Nanogap break junctions for molecular detection of cancer
9.5.2 Biomechanical discrimination of cancer cells using solid-state micropores
10 Predictive Methodologies for Design of Bone Tissue Engineering Scaffolds
10.1.1 Bio and synthetic polymers and nanoscale additives
10.1.2 Polymer scaffold manufacturing methods in laboratory and manufacturing technologies
10.1.2.1 Particulate leaching
10.1.2.4 Textiles techniques
10.1.2.5 Solid free-form (SFF) fabrication
10.1.2.6 Three-dimensional printing
10.1.2.7 Fused deposition modeling
10.2 In vitro Mechanical Properties: Methods and Challenges
10.2.2 Molecular modeling
10.2.4 Degradation of polymers and nanocomposites
10.3 Molecular Modeling for Design of Scaffolds
10.3.1 Successful material design in polymer clay nanocomposite
10.3.2 MD for tissue engineering scaffolds
10.4 Use of FE Methods for Predictive Capabilities of Scaffold Properties
10.5 Degradation of Scaffolds in Cell Culture Media and Modeling Degradation
10.6 Development of Multiscale Modeling Strategies for Scaffold Mechanics
10.8 Perspectives and Future Directions on the in silico Approach to Scaffold Design
11 Ethical Issues in Biomaterials Research
11.2 Ethical Issues With Emerging Technologies
11.2.1 Nanobiotechnology and ethics
11.2.2 Stem cell research and ethics
11.2.3 Tissue engineering
11.3 Cost versus Benefit Analysis
11.4 Resource Allocation for Biomedical Research
11.5 Ethical Issues With Authorship
11.7 Current Challenges and Future Directions
11.8 Guidelines for Ethical Practice in Biomaterials Research
12 Research on Bone Disorders—From Ideas to Clinical Use Product—The Path to Commercialization
12.2 What is the Path to Commercialization?
12.3 The Research Topic—The Big Idea. Is it really that Big?
12.4 The Big Idea—Short-term and Near-term Research
12.6 The Patent—A Step to Monetization of Research and the Big Idea
12.7 Claims—Are They Broad Enough to Keep the Competition out of This Space?
12.8 Freedom to Practice/Operate—Can Some Other Patent Stop This Technology?
12.9 What Are the Regulations Around This Big Idea Product?
12.10 What Is the Cost of Making This Product?
13 Current Challenges and Future Needs in Biomaterials and Devices for Bone Disorders
13.2 Current Challenges and Future Needs